290 related articles for article (PubMed ID: 35461083)
1. Naloxone administration among opioid-involved overdose deaths in 38 United States jurisdictions in the State Unintentional Drug Overdose Reporting System, 2019.
Quinn K; Kumar S; Hunter CT; O'Donnell J; Davis NL
Drug Alcohol Depend; 2022 Jun; 235():109467. PubMed ID: 35461083
[TBL] [Abstract][Full Text] [Related]
2. Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island.
Nolen S; Zang X; Chatterjee A; Behrends CN; Green TC; Kumar A; Linas BP; Morgan JR; Murphy SM; Walley AY; Yan S; Schackman BR; Marshall BDL
Addiction; 2022 May; 117(5):1372-1381. PubMed ID: 34825427
[TBL] [Abstract][Full Text] [Related]
3. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
[TBL] [Abstract][Full Text] [Related]
4. Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174
[TBL] [Abstract][Full Text] [Related]
5. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
[TBL] [Abstract][Full Text] [Related]
6. Impact of the naloxone standing order on trends in opioid fatal overdose: an ecological analysis.
Taylor M; Pradhan A; Ogando YM; Shaya F
Am J Drug Alcohol Abuse; 2022 May; 48(3):338-346. PubMed ID: 35467459
[No Abstract] [Full Text] [Related]
7. Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose.
Weiner SG; Carroll AD; Brisbon NM; Rodriguez CP; Covahey C; Stringfellow EJ; DiGennaro C; Jalali MS; Wakeman SE
J Subst Abuse Treat; 2022 Aug; 139():108785. PubMed ID: 35537918
[TBL] [Abstract][Full Text] [Related]
8. Disparities in opioid overdose survival and naloxone administration in Pennsylvania.
Holmes LM; Rishworth A; King BH
Drug Alcohol Depend; 2022 Sep; 238():109555. PubMed ID: 35810621
[TBL] [Abstract][Full Text] [Related]
9. Characterizing and combating the opioid epidemic in the Los Angeles County jail system.
Tran NT; Muradian IK; Qureshi N; Singh J; Henderson SO
J Subst Use Addict Treat; 2023 Apr; 147():208984. PubMed ID: 36841073
[TBL] [Abstract][Full Text] [Related]
10. Legacies of the war on drugs: Next of kin of persons who died of opioid overdose and harm reduction interventions in Philadelphia.
Uzwiak BA; Hudgins A; Pizzicato LN
Int J Drug Policy; 2021 Nov; 97():103351. PubMed ID: 34252788
[TBL] [Abstract][Full Text] [Related]
11. Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island.
Zang X; Macmadu A; Krieger MS; Behrends CN; Green TC; Morgan JR; Murphy SM; Nolen S; Walley AY; Schackman BR; Marshall BD
Int J Drug Policy; 2021 Dec; 98():103435. PubMed ID: 34482264
[TBL] [Abstract][Full Text] [Related]
12. Regional and temporal effects of naloxone access laws on opioid overdose mortality.
Cataife G; Dong J; Davis CS
Subst Abus; 2021; 42(3):329-338. PubMed ID: 31951788
[TBL] [Abstract][Full Text] [Related]
13. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
[TBL] [Abstract][Full Text] [Related]
14. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
McDonald R; Campbell ND; Strang J
Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
[TBL] [Abstract][Full Text] [Related]
15. Patient perceptions of higher-dose naloxone nasal spray for opioid overdose.
Strickland JC; Marks KR; Smith KE; Ellis JD; Hobelmann JG; Huhn AS
Int J Drug Policy; 2022 Aug; 106():103751. PubMed ID: 35636070
[TBL] [Abstract][Full Text] [Related]
16. Harm reduction in the Heartland: public knowledge and beliefs about naloxone in Nebraska, USA.
Schlosser A; Habecker P; Bevins R
Harm Reduct J; 2022 Mar; 19(1):22. PubMed ID: 35246153
[TBL] [Abstract][Full Text] [Related]
17. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
[TBL] [Abstract][Full Text] [Related]
18. Legal requirements and recommendations to prescribe naloxone.
Haffajee RL; Cherney S; Smart R
Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
[TBL] [Abstract][Full Text] [Related]
19. A qualitative examination of naloxone access in three states: Connecticut, Kentucky, and Wisconsin.
Spector AL; Galletly CL; Christenson EA; Montaque HDG; Dickson-Gomez J
BMC Public Health; 2022 Jul; 22(1):1387. PubMed ID: 35854278
[TBL] [Abstract][Full Text] [Related]
20. Naloxone Knowledge and Attitudes of Juvenile Residents in a Detention Setting.
Hammond A; Obrecht J; Odunuyi O; Magloire P; Walsh S
J Correct Health Care; 2022 Jun; 28(3):148-154. PubMed ID: 35263179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
